Literature DB >> 8391994

The oxidation of alpha-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide.

N Hogg1, V M Darley-Usmar, M T Wilson, S Moncada.   

Abstract

Peroxynitrite is the product of the reaction between nitric oxide and superoxide. It is an oxidant which can also decompose to form the hydroxyl radical and nitrogen dioxide. In this report we show that a powerful oxidant with reactivity similar to that of the hydroxyl radical is formed from the generation of superoxide from xanthine oxidase and nitric oxide from S-nitroso-n-acetylpenicillamine (SNAP). Simultaneous generation of these two radicals by either xanthine oxidase/SNAP or the sydnonimine SIN-1 in the presence of low-density lipoprotein (LDL) results in the depletion of alpha-tocopherol and formation of its oxidised product alpha-tocopheroquinone. The mechanism of oxidation required both the formation of nitric oxide and superoxide. In contrast to the promotion of LDL oxidation by transition metals the oxidation of LDL by SIN-1 was not sensitive to the addition of exogenous lipid hydroperoxide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391994     DOI: 10.1016/0014-5793(93)81790-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Hemodynamics influences vascular peroxynitrite formation: Implication for low-density lipoprotein apo-B-100 nitration.

Authors:  Tzung K Hsiai; Juliana Hwang; Mark L Barr; Adria Correa; Ryan Hamilton; Mohammad Alavi; Mahsa Rouhanizadeh; Enrique Cadenas; Stanley L Hazen
Journal:  Free Radic Biol Med       Date:  2006-11-21       Impact factor: 7.376

2.  Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro.

Authors:  E A Podrez; D Schmitt; H F Hoff; S L Hazen
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  In vitro studies of interactions of NO. donor drugs with superoxide and hydroxyl radicals.

Authors:  F Dalloz; V Maupoil; S Lecour; F Briot; L Rochette
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

4.  17beta-Estradiol reverses shear-stress-mediated low density lipoprotein modifications.

Authors:  Juliana Hwang; Mahsa Rouhanizadeh; Ryan T Hamilton; Tiantian C Lin; Jason P Eiserich; Howard N Hodis; Tzung K Hsiai
Journal:  Free Radic Biol Med       Date:  2006-04-26       Impact factor: 7.376

5.  Nitrite reductase activity of cytochrome c.

Authors:  Swati Basu; Natalia A Azarova; Michael D Font; S Bruce King; Neil Hogg; Mark T Gladwin; Sruti Shiva; Daniel B Kim-Shapiro
Journal:  J Biol Chem       Date:  2008-09-28       Impact factor: 5.157

6.  Melanoma cell destruction in the microvasculature of perfused hearts is reduced by pretreatment with vitamin E.

Authors:  P A Albertsson; U Nannmark; B R Johansson
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

Review 7.  Nitric oxide, platelet function, myocardial infarction and reperfusion therapies.

Authors:  David Alonso; Marek W Radomski
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

8.  Predictive Potential of Twenty-Two Biochemical Biomarkers for Coronary Artery Disease in Type 2 Diabetes Mellitus.

Authors:  Edimar Cristiano Pereira; Marcelo Chiara Bertolami; André Arpad Faludi; Osmar Monte; Hermes Toros Xavier; Tiago Veiga Pereira; Dulcineia Saes Parra Abdalla
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

9.  Alpha-fetoprotein, identified as a novel marker for the antioxidant effect of placental extract, exhibits synergistic antioxidant activity in the presence of estradiol.

Authors:  Hye Yeon Choi; Seung Woo Kim; BongWoo Kim; Hae Na Lee; Su-Jeong Kim; Minjung Song; Sol Kim; Jungho Kim; Young Bong Kim; Jin-Hoi Kim; Ssang-Goo Cho
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

10.  Nitric oxide function in atherosclerosis.

Authors:  K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.